Join the club for FREE to access the whole archive and other member benefits.

Big Data

More data is being generated than can be analysed - but enough of it is being studied to spot patterns in behaviour and genes to speed up drug discovery and development.

Though the data scientists need to make sure they feed in the right data. For example, in a study designed to detect hip fractures, it turned out the AI was using the patient's age and particularly the imaging device model to make its prediction. This worked because portable scanners are only used then the patient is too immobile to get to a hospital - and this limitation turned out to be a bigger indicator than any details on the image itself.


Click on resource name for more details.


Global leader in digital therapeutics that combines the power of AI with wearables data to enable personalized care

Deep Medicine


In Deep Medicine, leading physician Eric Topol reveals how artificial intelligence can help

Breath of Health (BOH)

Artificial intelligence company for early disease detection

Deep Longevity

AI to track the rate of ageing at the molecular, cellular, tissue, organ, system, physiological, and psychological levels

Evidence Based Medicine

EBM is the conscientious, explicit and judicious use of current best evidence in making decisions about the care of individual patients


Combating aging and associated diseases. An Alphabet (Google) subsidiary.


Developing a broad pipeline of therapies to extend human healthspan and lifespan

Dmitry Kaminskiy

Managing partner at Deep Knowledge Ventures


AI-powered platform for drug discovery and drug repurposing for age-related diseases.


Company developing AI systems for solving problems.

More Big Data resources

Recent News

New AI tool predicts genetic mutations that could cause disease

The Guardian - 19-Sep-2023

AlphaMissense is a game-changer in genetic research for human health


AI startup Inceptive to use $100M funding for novel medicines

Longevity Technology - 08-Sep-2023

Developing "biological software" for effective and affordable mRNA drug design


Genesis Therapeutics raised $200M in series B for AI-driven drug discovery

Longevity Technology - 22-Aug-2023

Funds to help AI-discovered drugs enter clinical trials and expand its pipeline


New proteins with shapeshifting abilities could transform biotechnology

Singularity Hub - 22-Aug-2023

AI can now design proteins that change shape in response to external stimuli


AI identifies new senolytics that could treat age-related diseases (LEAF) - 09-Aug-2023

Three natural compounds identified, paving the way for new treatments

More Big Data News